Puttur court quasheshate speech' case against PFI leaders, Rajashekhar

The Central Board of Secondary Education (CBSE) has rationalised the syllabus for classes IX to XII for the academic year 2020-21 by up to 30 per cent to make up for academic loss caused due to COVID-19, Union HRD Minister Ramesh Pokhriyal 'Nishank' announced on Tuesday.

"Looking at the extraordinary situation prevailing in the country and the world, CBSE was advised to revise the curriculum and reduce course load for the students of classes IX to XII.

"To aid the decision, a few weeks back I also invited suggestions from all educationists on the reduction of syllabus for students and I am glad to share that we received more than 1.5K suggestions. Thank you, everyone, for the overwhelming response," Nishank tweeted.

"Considering the importance of learning achievement, it has been decided to rationalize syllabus up to 30 per cent by retaining the core concepts," he added.

Jan 31: A bunch of fishermen in Kerala is being praised for releasing an endangered shark back into water. A video posted on Twitter shows the fishermen releasing the whale shark that was trapped in their nets back into the sea.

The video was posted on Twitter by InSeason Fish - a group working towards environmental conservation, sustainable fisheries and healthy oceans. Filmed in Kerala's Kozhikode, it shows fishermen on a fishing vessel with the huge whale shark.

Whale sharks are the largest fish in the ocean and can reach up to 40 feet in length. Distinguished by their white spots, this shark is on International Union for Conservation of Nature's list of endangered species.

In the video, at least seven fishermen are seen working together to lift the thrashing whale shark up with the help of ropes and releasing it into the water.

Watch the video below:

Fishermen from Kozhikode, #Kerala release an Endangered #WhaleShark. Respect! We should celebrate their actions. Please RT! Make them Heroes!@dhanyarajendran @Advaidism @jamewils @vivek4wild @wti_org_india @BittuSahgal @SanctuaryAsia @SwatiWild @GargiRawat @bahardutt @rickykej pic.twitter.com/uRz9eqPgG9

— InSeason Fish (@InSeasonFish) January 28, 2020

The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar. 

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”

The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.

The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.

The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.

Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. 

The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.